| Thu, Jul 9, 2009 | | • | VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Thu 4:31pm)
| | Wed, Jul 8, 2009 | | • | Stocks Worth Waiting For
at Motley Fool (Wed, Jul 8)
| | • | 5 Cold Stocks Heating Up
at Motley Fool (Wed, Jul 8)
| | Tue, Jul 7, 2009 | | • | Jeffrey Leiden M.D., Ph.D. and Dennis Winger Join Vertex Pharmaceuticals' Board of Directors
Business Wire (Tue, Jul 7)
| | • | This Just In: Upgrades and Downgrades
at Motley Fool (Tue, Jul 7)
| | • | PowerRatings Review and Update: VRTX, NDN, ZEUS
TradingMarkets.com (Tue, Jul 7)
| | Mon, Jul 6, 2009 | | • | Eyeing Ebay As A Swing Trade
at Forbes.com (Mon, Jul 6)
| | • | The Wrong Way to Invest in the Right Stocks
at Motley Fool (Mon, Jul 6)
| | Tue, Jun 30, 2009 | | • | Biotech Calendar: Key Clinical Trial Dates
at TheStreet.com (Tue, Jun 30)
| | Mon, Jun 29, 2009 | | • | Funding From an Unlikely Place
at Motley Fool (Mon, Jun 29)
| | Fri, Jun 26, 2009 | | • | Health Care Funds Get Obama Bounce
at TheStreet.com (Fri, Jun 26)
| | Tue, Jun 23, 2009 | | • | Vertex Pharmaceuticals Announces Webcast of its Presentation at the 2009 Piper Jaffray Europe Conference
Business Wire (Tue, Jun 23)
| | • | Ad agencies remember good old days
at bizjournals.com (Tue, Jun 23)
| | Fri, Jun 12, 2009 | | • | Thomas Weisel analyst rates Idenix 'Overweight'
AP (Fri, Jun 12)
| | Thu, Jun 11, 2009 | | • | VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of
EDGAR Online (Thu, Jun 11)
| | • | Four Hot Biotech Stocks to Buy: Analyst
at CNBC (Thu, Jun 11)
| | Wed, Jun 10, 2009 | | • | UPDATE - Vertex sees profit soon after hep C drug launch-CEO
at Reuters (Wed, Jun 10)
| | Mon, Jun 8, 2009 | | • | Vertex Pharmaceuticals Announces Agreements to Exchange an Additional $40.2 Million of its 2013 Convertible Senior Subordinated Notes into Common Stock
Business Wire (Mon, Jun 8)
| | • | Vertex swaps $103.3 million in notes for stock
AP (Mon, Jun 8)
| | • | Vertex Pharmaceuticals Announces Agreements to Exchange $103.3 Million of its 2013 Convertible Senior Subordinated Notes into Common Stock
Business Wire (Mon, Jun 8)
|
Add VRTX News to My Yahoo!:
 
| |
|
0.06% Nasdaq 0.00%
Headlines
